Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.71 |
| ▸ | ESR1 | P03372 | 4/20 | 0.65 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.65 |
| ▸ | ADRA2A | P08913 | 3/20 | 0.58 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.58 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.58 |
| ▸ | TACR2 | P21452 | 2/20 | 0.58 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.58 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.58 |
| ▸ | SHBG | P04278 | 1/20 | 0.58 |
| ▸ | TP53 | P04637 | 1/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.58 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.58 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.58 |
| ▸ | HTR2C | P28335 | 1/20 | 0.58 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.58 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1172078 | 0.92 | CA2 (0.68) | CA2ESR1ESR2ADRA2ASLC6A2 | |
| SCHEMBL10405809 | 0.90 | ESR1 (0.65) | CA2ESR1ESR2ADRA2ASLC6A2 | |
| SCHEMBL1070427 | 0.90 | ESR1 (0.65) | CA2ESR1ESR2ADRA2ASLC6A2 | |
| SCHEMBL8055358 | 0.90 | ESR1 (0.65) | CA2ESR1ESR2ADRA2ASLC6A2 | |
| SCHEMBL11228648 | 0.90 | ESR1 (0.65) | CA2ESR1ESR2ADRA2ASLC6A2 | |
| SCHEMBL7368216 | 0.90 | ESR1 (0.65) | CA2ESR1ESR2ADRA2ASLC6A2 | |
| SCHEMBL239040 | 0.89 | CA2 (0.60) | CA2ESR1ESR2ADRA2ASLC6A2 | |
| SCHEMBL17072086 | 0.87 | ESR1 (0.56) | CA2ESR1ESR2ADRA2ASLC6A2 | |
| SCHEMBL17072098 | 0.87 | ESR1 (0.56) | CA2ESR1ESR2ADRA2ASLC6A2 | |
| SCHEMBL1171041 | 0.86 | ESR1 (0.77) | CA2ESR1ESR2ADRA2ASLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 927 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250000924-A1 | Composition for the prevention, improvement or treatment of allergic disease comprising an extract of Taxus cuspidata as an active ingredient | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2025-01-02 | — | — | US | claimed |
| CN-117836262-A | Separation of dialkylene phenol glycol ethers | 陶氏环球技术有限责任公司 | 2024-04-05 | — | — | CN | claimed |
| CN-115703883-B | Catalyst and preparation method of polycarbonate | 华为技术有限公司 | 2023-11-28 | — | — | CN | claimed |
| CN-115703883-A | Catalyst and preparation method of polycarbonate | 华为技术有限公司 | 2023-02-17 | — | — | CN | claimed |
| CN-112812287-B | Method for preparing polycarbonate by ionic liquid catalysis | 中国科学院过程工程研究所 | 2022-11-29 | — | — | CN | claimed |
| CN-114957176-A | Human angiotensin converting enzyme inhibitor compound and synthetic method | 河南中医药大学第一附属医院 | 2022-08-30 | — | — | CN | claimed |
| CN-107974080-B | Polyamide moulding compositions and multilayer structures made therefrom | EMS专利股份公司 | 2021-07-20 | — | — | CN | claimed |
| CN-111205448-B | Method for preparing polycarbonate by catalysis | 中国科学院过程工程研究所 | 2021-07-02 | — | — | CN | claimed |
| CN-112812287-A | Method for preparing polycarbonate by ionic liquid catalysis | 中国科学院过程工程研究所 | 2021-05-18 | — | — | CN | claimed |
| CN-112479823-A | Method for preparing 4-alkylphenol by auto-reforming hydrogenolysis of lignin or lignin oil | 华东理工大学 | 2021-03-12 | — | — | CN | claimed |
| US-6066200-A | COMPRISING A SOLID UREA COMPOUND, AN ALCOHOL, A LIGHTFASTNESS COMPONENT, A LIGHTFAST ANTIOXIDANT, AND A COLORANT | XEROX CORPORATION (US) | 2000-05-23 | — | — | US | claimed |
| US-5922117-A | Ink compositions containing alcohols | XEROX CORPORATION (US) | 1999-07-13 | — | — | US | claimed |
| US-5663022-A | Recording sheets | XEROX CORPORATION (US) | 1997-09-02 | — | — | US | claimed |
| EP-0568819-B1 | Process for the preparation of 3-(hydroxyphenyl)-propionaldehydes and optionally the preparation of 3-(hydroxyphenyl)-propanols | BASF AG (DE) | 1996-01-03 | — | — | EP | claimed |
| EP-0674232-A2 | Recording sheets | XEROX CORPORATION (US) | 1995-09-27 | — | — | EP | claimed |
| CN-1091141-A | The enzymatic that tensio-active agent is used for phenol and aromatic amines polymer synthesizes | UNIV JILIN (CN) | 1994-08-24 | — | — | CN | claimed |
| CN-1087920-A | The enzymatic of phenol and aromatic amine high molecular polymer is synthetic | UNIV JILIN (CN) | 1994-06-15 | — | — | CN | claimed |
| US-5304685-A | Preparation of 3-(hydroxyphenyl)propionaldehydes and their hydrogenation to 3-(hydroxyphenyl)propanols | BASF AKTIENGESELLSCHAFT (DE) | 1994-04-19 | — | — | US | claimed |
| EP-0443573-A2 | HIV protease inhibitors containing derived amino acids | BIO-MEGA/BOEHRINGER INGELHEIM RESEARCH INC. (CA) | 1991-08-28 | — | — | EP | claimed |
| EP-0443560-A2 | HIV protease inhibitors | BIO-MEGA/BOEHRINGER INGELHEIM RESEARCH INC. (CA) | 1991-08-28 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250000924-A1 | Composition for the prevention, improvement or treatment of allergic disease comprising an extract of Taxus cuspidata as an active ingredient | SERPINB1, TSLP, CMA1 | CA2 2744/4885ESR1 1603/4885ESR2 1594/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.